Critical Survey: Avalon GloboCare (ALBT) and Its Competitors

Avalon GloboCare (NASDAQ:ALBTGet Rating) is one of 60 public companies in the “Management consulting services” industry, but how does it weigh in compared to its rivals? We will compare Avalon GloboCare to related companies based on the strength of its dividends, earnings, profitability, risk, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares Avalon GloboCare and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Avalon GloboCare -955.48% -460.58% -97.43%
Avalon GloboCare Competitors -56.87% -79.82% -7.02%

Analyst Recommendations

This is a summary of recent ratings for Avalon GloboCare and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon GloboCare 0 0 0 0 N/A
Avalon GloboCare Competitors 54 447 965 15 2.64

As a group, “Management consulting services” companies have a potential upside of 45.90%. Given Avalon GloboCare’s rivals higher possible upside, analysts plainly believe Avalon GloboCare has less favorable growth aspects than its rivals.

Volatility & Risk

Avalon GloboCare has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Avalon GloboCare’s rivals have a beta of 1.76, indicating that their average stock price is 76% more volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Avalon GloboCare $1.39 million -$9.09 million -2.62
Avalon GloboCare Competitors $1.54 billion $108.11 million 13.58

Avalon GloboCare’s rivals have higher revenue and earnings than Avalon GloboCare. Avalon GloboCare is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

0.9% of Avalon GloboCare shares are held by institutional investors. Comparatively, 41.3% of shares of all “Management consulting services” companies are held by institutional investors. 64.0% of Avalon GloboCare shares are held by insiders. Comparatively, 29.2% of shares of all “Management consulting services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Avalon GloboCare rivals beat Avalon GloboCare on 8 of the 9 factors compared.

Avalon GloboCare Company Profile

(Get Rating)

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. It operates through the following segments: Real Property Operating, Medical Related Consulting Services, and Development Services & Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.